Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/23/1999WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999WO1999065539A2 Tumescent solution
12/23/1999WO1999065528A1 Imprinted copolymers for selective adsorption of cholesterol
12/23/1999WO1999065527A1 Solution comprising prostaglandins and benzyl alcohol
12/23/1999WO1999065525A1 Ocular tension lowering agents and phosphoric ester derivatives
12/23/1999WO1999065505A1 Oregano for the treatment of internal parasites and protozoa
12/23/1999WO1999065504A1 Extraction method, pharmaceutical composition and a cosmetic composition
12/23/1999WO1999065501A1 A process for the treatment of organophosphate poisoning
12/23/1999WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999WO1999065499A1 Cyclophosphamide coated tablets
12/23/1999WO1999065498A1 Agents for relieving side effects of adrenal cortex hormone
12/23/1999WO1999065497A1 Vaginal active agent delivery procedures and formulations thereof
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065493A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/23/1999WO1999065492A1 Inhibition of serotonin reuptake
12/23/1999WO1999065491A1 Method of treatment
12/23/1999WO1999065490A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
12/23/1999WO1999065489A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065487A1 Inhibitors of serotonin reuptake
12/23/1999WO1999065486A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065485A1 Use of benzomorphan derivatives as an analgesic
12/23/1999WO1999065484A1 New use
12/23/1999WO1999065483A1 Mycobacterial inhibitors
12/23/1999WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999WO1999065481A1 Liposomal formulations of busulphan
12/23/1999WO1999065479A1 Method of treating an autoimmune disorder
12/23/1999WO1999065478A1 Therapeutic compositions and methods of use
12/23/1999WO1999065477A1 Anaesthetic compositions
12/23/1999WO1999065476A2 COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO)
12/23/1999WO1999065475A2 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
12/23/1999WO1999065474A2 Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
12/23/1999WO1999065471A1 Method for making tablets with active principle sustained-release
12/23/1999WO1999065469A2 Processes to generate submicron particles of water-insoluble compounds
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065464A1 Pharmaceutical formulations for aerosols with two or more active substances
12/23/1999WO1999065462A2 Use of aminosterol derivatives as chloride ionphores
12/23/1999WO1999065461A2 Cationic amphiphile micellar complexes
12/23/1999WO1999065460A2 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist
12/23/1999WO1999065457A1 Method of making antiperspirant powders
12/23/1999WO1999065456A1 Foaming composition for hair care
12/23/1999WO1999065451A2 Caspases and apoptosis
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065430A1 Adhesively applied external nasal strips and dilators containing medications and fragrances
12/23/1999WO1999065311A1 Composition for keeping away vermin
12/23/1999WO1999065310A1 Il-8 receptor antagonists
12/23/1999WO1999065309A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999WO1999065306A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999WO1999065303A1 Composition and method for treating penile erectile dysfunction
12/23/1999WO1999053904A3 Softgel-compatible composition containing retinol
12/23/1999WO1999052516A3 Acylpeptide protease inhibitors to enhance cognitive function
12/23/1999WO1999051213A3 The use of polyamines in the treatment of dermatological symptoms
12/23/1999WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999WO1998054171A8 Novel form of s-omeprazole
12/23/1999WO1996002535A8 Process for synthesis of substituted sulphoxides
12/23/1999WO1996001622A8 New oral pharmaceutical formulation containing magnesium salt of omeprazole
12/23/1999DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999DE19828881A1 Industrial preparation of prostane derivatives, especially iloprost, having reduced content of decomposition products
12/23/1999DE19827732A1 Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
12/23/1999DE19827679A1 New pyrazolo(3,4-d)pyrimidine derivative adenosine A3 receptor antagonists, used for treating epilepsy, asthma or allergy
12/23/1999DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
12/23/1999DE19827523A1 New unsaturated 14,15-cyclopropano-androstanes useful in fertility control and for treating e.g. hypogonadism, endometriosis or mammary carcinoma
12/23/1999DE19827522A1 New derivatives of 19-norandrostane useful in fertility control or treatment of e.g. endometriosis, mammary carcinoma or hypogonadism
12/23/1999DE19827387A1 Use of ligands of the high affinity binding site of diisopropyl-fluorophosphate in treatment of central nervous system disorders
12/23/1999DE19826843A1 Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Imidazotriazolopyrimidine new, processes for their preparation and their use as medicaments
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999DE19826796A1 Combined preparation having antiprotozoal activity, useful for simultaneously treating malaria and trypanosomiasis
12/23/1999DE19826793A1 Stable diminazene diaceturate preparation having antiprotozoal activity, used e.g. for treating malaria or trypanosomiasis
12/23/1999DE19825591A1 Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata Pharmaceutical combinations to offset a deficit testosterone in men with prostate while protecting the
12/23/1999CA2755266A1 Intermediates for preparing macrocyclic analogs
12/23/1999CA2709735A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999CA2677519A1 Aryl substituted olefinic amines and their use as cholinergic receptors agonists
12/23/1999CA2342990A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
12/23/1999CA2337603A1 Prenyl transferase inhibitors
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335638A1 Cationic amphiphile micellar complexes
12/23/1999CA2335464A1 Novel thiolesters and uses thereof
12/23/1999CA2335435A1 Imidazolyl derivatives
12/23/1999CA2335361A1 Medicament for reducing side effects of adrenocortical hormones
12/23/1999CA2335336A1 Inhibition of serotonin reuptake
12/23/1999CA2335322A1 Inhibitors of serotonin reuptake
12/23/1999CA2335306A1 Caspases and apoptosis
12/23/1999CA2335303A1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations
12/23/1999CA2335295A1 Methods for increasing levels of acetylcholine
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335292A1 Il-8 receptor antagonists
12/23/1999CA2335255A1 Vaginal active agent delivery procedures and formulations thereof
12/23/1999CA2335236A1 Method of treatment
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2335134A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999CA2335112A1 Therapeutic combinations for musculoskeletal frailty
12/23/1999CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999CA2334924A1 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
12/23/1999CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999CA2334836A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999CA2334817A1 Triazolo-pyrimidines as ligands for gaba receptors
12/23/1999CA2334815A1 Composition for treating cartilage disease
12/23/1999CA2334805A1 Use of aminosterol derivatives as chloride ionphores
1 ... 6390 6391 6392 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 ... 7860